Literature DB >> 8786051

Perinatal transmission of hepatitis B virus infection and vaccination in China.

J L Yao1.   

Abstract

Hepatitis B remains one of the most important infectious diseases in China. In 1980, an overall hepatitis B virus (HBV) infection rate of 42.6% was reported and a hepatitis B surface antigen (HBsAg) carrier rate of 10.3%. HBsAg positivity among children under 1 year of age ranged from 5.1% in Beijing to 7% in Guangdong. A peak in carrier rate was observed in 7 to 14 year olds, reaching 24% in Guangdong. During the past decade, there has been no significant change in overall HBV carrier rates. However, in areas where hepatitis B vaccination for all neonates has been introduced, a decline in HBsAg positivity in lower age groups has been observed. Perinatal transmission is believed to account for 35-50% of carriers although horizontal transmission is also important, particularly within families. Infants born to HBeAg positive carrier mothers are at even greater risk of infection. HBV infection during childhood leads to an increased risk of serious longterm sequelae, including hepatocellular carcinoma (HCC). It is hoped that universal childhood immunisation will allow control of HBV infections in China within a few generations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786051      PMCID: PMC1398041          DOI: 10.1136/gut.38.suppl_2.s37

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

Review 1.  Hepatitis B (prevention).

Authors:  Suzanne Norris; Abdul Mohsen
Journal:  BMJ Clin Evid       Date:  2009-09-23

2.  Prevention of vertical transmission of hepatitis B: an observational study.

Authors:  Ai Kubo; Lyle Shlager; Amy R Marks; Dena Lakritz; Colette Beaumont; Kim Gabellini; Douglas A Corley
Journal:  Ann Intern Med       Date:  2014-06-17       Impact factor: 25.391

3.  Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China.

Authors:  Tao Bian; Hongxia Yan; Liping Shen; Feng Wang; Shuang Zhang; Yanqiang Cao; Shuo Zhang; Yong Zhang; Shengli Bi
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

4.  Evaluation and management of hepatitis B in pregnancy: a survey of current practices.

Authors:  Joseph Ahn; Suhail B Salem; Stanley Martin Cohen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-09

5.  Low level of Hepatitis B knowledge and awareness among pregnant women in the Kintampo North Municipality: implications for effective disease control.

Authors:  Martha Ali Abdulai; Frank Baiden; George Adjei; Seth Owusu-Agyei
Journal:  Ghana Med J       Date:  2016-09

6.  A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.

Authors:  Xiaoyong Fu; Lu Tan; Shuqin Liu; Honghai Li; Lei Chen; Jianmin Qin; Mengchao Wu; Hongyang Wang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-19       Impact factor: 4.553

7.  Safety, immunization coverage and determinants of a new kind of Hepatitis B vaccine firstly applied in Ningbo, China.

Authors:  Sijia Yang; Xiao Ma; Hongxia Ni; Shaoying Zhou; Danbiao Hu; Honghui Shi; Xiaoying Chen; Hongjun Dong; Guozhang Xu
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

8.  Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women.

Authors:  Pai-Jong Stacy Tsai; Ann Chang; Seiji Yamada; Naoky Tsai; Marguerite Lisa Bartholomew
Journal:  Dig Dis Sci       Date:  2014-06-05       Impact factor: 3.199

9.  Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.

Authors:  Vijayakumar Velu; Subhadra Nandakumar; Saravanan Shanmugam; Suresh-Sakharam Jadhav; Prasad-Suryakant Kulkarni; Sadras-Panchatcharam Thyagarajan
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

10.  Hepatitis B virus translocates across a trophoblastic barrier.

Authors:  Purnima Bhat; David A Anderson
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.